WO2014028780A3 - Antifungal compounds and methods of use - Google Patents

Antifungal compounds and methods of use

Info

Publication number
WO2014028780A3
WO2014028780A3 PCT/US2013/055211 US2013055211W WO2014028780A3 WO 2014028780 A3 WO2014028780 A3 WO 2014028780A3 US 2013055211 W US2013055211 W US 2013055211W WO 2014028780 A3 WO2014028780 A3 WO 2014028780A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
methods
use
antifungal compounds
antifungal
compounds
Prior art date
Application number
PCT/US2013/055211
Other languages
French (fr)
Other versions
WO2014028780A2 (en )
Inventor
Bassam Damaj
Richard Martin
Original Assignee
Nexmed Holdings, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Abstract

Disclosed herein are compositions and methods for treating fungus infections of skin using tolnaftate and other antifungal agents.
PCT/US2013/055211 2012-08-15 2013-08-15 Antifungal compounds and methods of use WO2014028780A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US201261683710 true 2012-08-15 2012-08-15
US61/683,710 2012-08-15

Publications (2)

Publication Number Publication Date
WO2014028780A2 true WO2014028780A2 (en) 2014-02-20
WO2014028780A3 true true WO2014028780A3 (en) 2014-05-01

Family

ID=50101613

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/055211 WO2014028780A3 (en) 2012-08-15 2013-08-15 Antifungal compounds and methods of use

Country Status (1)

Country Link
WO (1) WO2014028780A3 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090258098A1 (en) * 2008-04-15 2009-10-15 Lane Rolling Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
WO2011075654A1 (en) * 2009-12-18 2011-06-23 Exodos Life Sciences Limited Partnership Methods and compositions for treating inflammation of skin
US20110237558A1 (en) * 2008-10-03 2011-09-29 William Shifeng Stabilized composition for treating psoriasis
WO2012075107A2 (en) * 2010-12-02 2012-06-07 Nexmed Holdings, Inc. Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090258098A1 (en) * 2008-04-15 2009-10-15 Lane Rolling Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
US20110237558A1 (en) * 2008-10-03 2011-09-29 William Shifeng Stabilized composition for treating psoriasis
WO2011075654A1 (en) * 2009-12-18 2011-06-23 Exodos Life Sciences Limited Partnership Methods and compositions for treating inflammation of skin
WO2012075107A2 (en) * 2010-12-02 2012-06-07 Nexmed Holdings, Inc. Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MEIER-DAVIS, SR ET AL.: 'Enhancing the Skin Flux of Tolnaftate Utilizing the Novel Excipient, Dodecyl-2-N,N-Dimethylaminopropionate (DDAIP).' JOURNAL OF PHARMACEUTICS & DRUG DELIVERY RESEARCH, [Online] vol. 1, no. 1, 13 August 2012, pages 1 - 3 Retrieved from the Internet: <URL:http://www.scitechnol.com/2325-960412325-9604-1-102.pdf> [retrieved on 2013-12-20] *

Also Published As

Publication number Publication date Type
WO2014028780A2 (en) 2014-02-20 application

Similar Documents

Publication Publication Date Title
WO2012027728A3 (en) Compositions and methods for targeted thermomodulation
WO2012103810A1 (en) Certain chemical entities, compositions, and methods
WO2012116237A3 (en) Heterocyclic compounds and uses thereof
WO2014172644A3 (en) Bicyclic heterocycles as fgfr inhibitors
WO2014100764A3 (en) Methods of inhibiting prmt5
WO2014096965A3 (en) Novel heterocyclic compounds as bromodomain inhibitors
WO2012162580A3 (en) Anti-viral compounds
WO2013188813A3 (en) Novel therapeutics for brain cancer
WO2010027792A8 (en) Treatment of sweating and hyperhidrosis
WO2014031859A3 (en) Compositions and methods relating to blood-based biomarkers of breast cancer
WO2013106689A8 (en) Hcv ns3 protease inhibitors
WO2013040227A3 (en) Therapeutic compounds
WO2015013635A3 (en) Inhibitors of transcription factors and uses thereof
WO2012138981A3 (en) New intermediates and processes for preparing ticagrelor
WO2011146819A3 (en) METHODS AND COMPOSITIONS FOR TREATMENT NF-κB-MEDIATED AND α7 INTEGRIN-SUPPRESSED DISEASES
CA2864120A1 (en) Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
EP3016948B8 (en) 2-acylaminothiazoles for the treatment of cancer
GB2514940B (en) Process for the treatment of ash, treated ash thus obtained and uses of treated ash
EP2822598A4 (en) Polymers having therapeutically active agents conjugated thereto, processes of preparing same and uses thereof
WO2012106680A8 (en) Methods and compositions for chemical drying and producing struvite
EP2651429A4 (en) Neuropeptide analogs, compositions, and methods for treating pain
EP2878302A4 (en) Composition for preventing or treating osteoarthrosis
EP2978434A4 (en) Compositions, formulations and methods of bio-balancing the ph of sterile isotonic saline and hypertonic saline solutions
WO2014011911A3 (en) Irak inhibitors and uses thereof
WO2011073279A3 (en) Cosmetic treatment method involving a compound capable of condensing in situ

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13829185

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 13829185

Country of ref document: EP

Kind code of ref document: A2